AHF Calls on WTO to Protect Affordable Medicines

Global health organization warns against policies that could limit access to vital drugs

Mar. 31, 2026 at 5:13pm

Got story updates? Submit your updates here. ›

A minimalist neon outline of a medicine bottle, its shape and details defined by glowing electric lines against a dark background, conceptually representing the importance of affordable pharmaceuticals.Global health advocates warn that new trade policies could jeopardize access to affordable medicines in developing countries.Los Angeles Today

The AIDS Healthcare Foundation (AHF) is urging governments attending the WTO 14th Ministerial Conference in Yaoundé, Cameroon, to ensure that any policies or agreements coming out of the meeting do not put affordable access to essential medicines at risk. AHF is concerned that certain trade policies being considered could restrict the availability of low-cost generic drugs in developing countries.

Why it matters

Access to affordable medicines is a critical global health issue, especially in low-income regions where many people struggle to afford the high prices of brand-name pharmaceuticals. AHF is worried that new WTO policies could undermine the availability of generic drug alternatives, which are often the only way for millions to obtain life-saving treatments.

The details

The WTO 14th Ministerial Conference is bringing together trade ministers from around the world to discuss a range of economic policies. AHF is specifically concerned about potential changes to intellectual property rules that could extend patent protections and delay the introduction of generic competition, effectively limiting access to affordable medicines.

  • The WTO 14th Ministerial Conference is taking place from March 30 to April 3, 2026 in Yaoundé, Cameroon.

The players

AIDS Healthcare Foundation (AHF)

A global non-profit organization that provides HIV/AIDS medical care and advocates for expanded access to affordable treatments.

Got photos? Submit your photos here. ›

What they’re saying

“We cannot allow trade policies to undermine access to essential medicines that millions of people in developing countries rely on. Governments must prioritize public health over corporate profits.”

— Michael Weinstein, President, AIDS Healthcare Foundation

What’s next

The WTO 14th Ministerial Conference will conclude on April 3, 2026, at which point any new trade policies or agreements that could impact access to affordable medicines will be announced.

The takeaway

This issue highlights the ongoing tension between promoting free trade and protecting public health. As the WTO meeting unfolds, global health advocates will be closely monitoring the outcomes to ensure that any new policies do not inadvertently restrict access to life-saving generic drugs in developing countries.